Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes

Diabetologia

Volumn 57, Issue 3, 2014, Pages 623-632

  Ang, Meidjie ^a   Meyer, Christian ^b   Brendel, Mathias D ^c   Bretzel, Reinhard G ^a   Linn, Thomas ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b FLORIDA HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Hypoglycaemia counterregulation; Pancreatic islet transplantation; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LACTIC ACID;

ADULT; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPOGLYCEMIA; MALE; METABOLISM; PANCREAS ISLET TRANSPLANTATION; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; LACTIC ACID; MALE; MUSCLE, SKELETAL; TREATMENT OUTCOME;

EID: 84894536916     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3120-9     Document Type: Article

References (31)

1. Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes 57:3169-3176
2. Bretzel RG, Jahr H, Eckhard M, Martin I, Winter D, Brendel MD (2007) Islet cell transplantation today. Langenbecks Arch Surg 392:239-253
3. Shalitin S, Phillip M (2008) Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy. Diabetes Care 31(Suppl 2):S121-S124
4. Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
5. Leitão CB, Tharavanij T, Cure P et al (2008) Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care 31:2113-2115
6. Barton FB, Rickels MR, Alejandro R et al (2012) Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 35:1436-1445
7. O'Connell PJ, Holmes-Walker DJ, Goodman D et al (2013) Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. Am J Transplant 13:1850-1858
8. Bergman RN (1989) Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38:1512-1527
9. Meyer C, Saar P, Soydan N et al (2005) A potential important role of skeletal muscle in human counterregulation of hypoglycemia. J Clin Endocrinol Metab 90:6244-6250
10. Meyer C, Hering BJ, Grossmann R et al (1998) Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation 66:233-240
11. Rickels MR, Schutta MH, Mueller R et al (2007) Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab 92:873-879
12. Rickels MR, Schutta MH, Mueller R et al (2005) Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes 54:3205-3211
13. The Diabetes Control and Complications Trial Research Group (1997) Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271-286
14. Shapiro AM, Lakey JR, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238
15. Wolfe R (1992) Radioactive and stable isotope tracers in biomedicine: Principles and practice of kinetic analysis. Wiley-Liss, New York
16. Debodo RC, Steele R, Altszuler N, Dunn A, Bishop JS (1963) On the hormonal regulation of carbohydrate metabolism; studies with C14 glucose. Recent Prog Horm Res 19:445-488
17. Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924
18. Radziuk J, Norwich KH, Vranic M (1974) Measurement and validation of nonsteady turnover rates with applications to the inulin and glucose systems. Fed Proc 33:1855-1864
19. Issekutz B Jr, Shaw WA, Issekutz AC (1976) Lactate metabolism in resting and exercising dogs. J Appl Physiol 40:312-319
20. Chiasson JL, Liljenquist JE, Lacy WW, Jennings AS, Cherrington AD (1977) Gluconeogenesis: methodological approaches in vivo. Fed Proc 36:229-235
21. Landau BR, Wahren J (1992) Nonproductive exchanges: the use of isotopes gone astray. Metabolism 41:457-459
22. Consoli A, Nurjahan N, Gerich JE, Mandarino LJ (1992) Skeletal muscle is a major site of lactate uptake and release during hyperinsulinemia. Metabolism 41:176-179
23. Heymsfield SB, McManus C, Stevens V, Smith J (1982) Muscle mass: reliable indicator of protein-energy malnutrition severity and outcome. Am J Clin Nutr 35:1192-1199
24. Kendall DM, Teuscher AU, Robertson RP (1997) Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes 46:23-27
25. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP (2002) Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 51:3428-3434
26. Magnusson I, Rothman DL, Gerard DP, Katz LD, Shulman GI (1995) Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 44:185-189
27. Hwang JH, Perseghin G, Rothman DL et al (1995) Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 95:783-787
28. Bischof MG, Krssak M, Krebs M et al (2001) Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes. Diabetes 50:392-398
29. Zhou H, Zhang T, Bogdani M et al (2008) Intrahepatic glucose flux as a mechanism for defective intrahepatic islet alpha-cell response to hypoglycemia. Diabetes 57:1567-1574
30. Foretz M, Hébrard S, Leclerc J et al (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 120:2355-2369
31. Adkins A, Basu R, Persson M et al (2003) Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes 52:2213-2220